December 23rd 2022
Paul J. Shaughnessy, MD, discusses the potential of the phase 1/2 FELIX trial to address unmet needs in relapsed/refractory B-cell acute lymphoblastic leukemia.
August 5th 2020
Paul J. Shaughnessy, MD, discusses the challenges faced with CAR T-cell therapy in hematologic malignancies.
August 4th 2020
Paul J. Shaughnessy, MD, discusses challenges with CAR T-cell therapy in relapsed/refractory hematologic malignancies.
July 30th 2020
Paul J. Shaughnessy, MD, discusses the promising future of CAR T-cell therapy in relapsed/refractory hematologic malignancies.
July 21st 2020
Paul J. Shaughnessy, MD, discusses the emergence of CAR T-cell therapy in hematologic malignancies.
July 17th 2020
Paul J. Shaughnessy, MD, discusses the available CAR T-cell therapies for relapsed/refractory hematologic malignancies.
April 4th 2019
Paul J. Shaughnessy, MD, medical director of adult blood and marrow transplant at the Texas Transplant Institute, discusses unanswered questions in the field of diffuse large B-cell lymphoma (DLBCL).
February 25th 2019
Paul J. Shaughnessy, MD, discusses stem cell mobilization in patients with lymphomas.